The largest database of trusted experimental protocols

Niopam 300

Manufactured by Bracco
Sourced in United Kingdom

Niopam 300 is a non-ionic, water-soluble iodinated contrast medium for use in diagnostic imaging procedures. It is a sterile, clear, colorless to pale yellow solution containing iohexol as the active ingredient.

Automatically generated - may contain errors

4 protocols using niopam 300

1

Evaluating Bead Suspendability and Catheter Delivery

Check if the same lab product or an alternative is used in the 5 most similar protocols
Bead suspendability and catheter delivery properties were evaluated in a syringe-based model to replicate the clinical practice as previously described by us in detail. Non-ionic contrast agents evaluated included iohexol (Omnipaque 350, GE Healthcare), iodixanol (Visipaque 320, GE), iomeprol (Iomeron 300 and 400, Bracco) and iopamidol (Niopam 300, Bracco) together with a range of bead sizes. Micro-catheters evaluated included 2.0 Fr Progreat® (Terumo, Somerset, NJ) a 2.4 Fr Renegade® (Boston Scientific Corp.) and 4.0 Fr Radiofocus Glidecath® (Terumo).
+ Open protocol
+ Expand
2

CT Angiography Protocol for Optimal Imaging

Check if the same lab product or an alternative is used in the 5 most similar protocols
During the study period, two CT scanners were in use at Nottingham University Hospitals NHS Trust where the study was conducted. The first was Ingenuity 128 (Phillips Healthcare, Best, The Netherlands) and the second was Optima CT660 (GE Healthcare, Milwaukee, WI, USA). These were calibrated weekly to ensure that quality assurance testing was met for the Hounsfield Unit (HU) density of air (HU = –1000) and water (HU = 0). Arterial and portovenous phase scans were obtained using intravenous (IV) administration of contrast medium (100 mL fixed dose of Iopamidol, Niopam 300, Bracco, Buckinghamshire, UK). The timings of different phase scans were standardized, first with an unenhanced scan, then the arterial phase performed at 10 to 20s, and finally the portovenous scan at 65s.
+ Open protocol
+ Expand
3

Computed Tomography Imaging of Tuberculosis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Computed Tomography (CT) scans were performed on sedated animals at 3, 7, 11 and 15 weeks following infectious challenge (16 slice Lightspeed CT scanner, GE Healthcare, Milwaukee, WI, USA), as previously described (23 (link)). Niopam 300 (2ml/kg i.v., Bracco, Milan, Itay) was used as a contrast agent. An expert medical consultant radiologist with expertise in respiratory diseases, including in non-human primates assessed the scans blinded to the animals’ treatment and clinical status. The number and lobar distribution of pulmonary lesions and other pathological abnormalities including nodular conglomeration, cavitation, consolidation (associated with alveolar pneumonia), lobular collapse, and the ‘tree-in-bud’ pattern associated with bronchocentric pneumonia, were recorded. Upper airways were assessed for bronchocele and wall thickening. Other body tissues were scored for enlargement, necrosis, cavitation and extrapulmonary foci of infection: lung associated lymph nodes, liver, kidneys, and spleen. Findings were scored, and composite scores for tuberculosis disease burden (a relative score comprising the following factors; number of lesions, presence and extent of physiological changes (26 (link)) pneumonia (sum of consolidation & tree-in-bud morphology scores) and total CT score (the sum of scores attributed to each tissue) were calculated.
+ Open protocol
+ Expand
4

Triple-Phase CT Imaging for Pancreatic Transplant Evaluation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Triple‐phase CTAP was performed using 64‐ or 256‐section CT systems (Siemen AG Healthcare, Camberley, Surrey, UK). Unenhanced imaging of the abdomen was performed to localize the pancreatic graft, followed by early arterial phase imaging of the pancreatic and renal grafts and portal phase imaging of the abdomen and pelvis. We administered 100 mL of iopamidol nonionic contrast (Niopam 300; Bracco, High Wycombe, Bucks, UK) at a rate of 3 mL per second. Images were reconstructed and reviewed at 2‐mm section thickness on the picture archive and communication system (PACS GE). The triple‐phase CT scans were performed for clinical/biochemical reasons, and no routine or protocol scans were performed. Intravenous fluid rehydration was considered in recipients with a raised creatinine of greater than 150 μmol/L. Routine USS is performed to evaluate the renal allograft; routine USS of the pancreatic graft is not performed in our unit.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!